The longevity supplement start-up with the aim to improve health-span
AVEA has raised €4.7M across 2 funding rounds from 3 investors, most recently a Seed round in Jul 2023. Based in Zug, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2023-07-04 | Seed | €2.3M | Maximon | View deal → |
| 2022-06-01 | Other | €2.4M | Longevity Co-Investment Fund,Maximon,The Longevity Company Builder | View deal → |
